Answers are grounded in this paper and cite their sources.
We report branched α-d-mannopyranosides as potent FimH antagonists that exploit the previously unexplored lipophilic region formed by Phe142 and Ile13.
No takes yet. Share an insight, caveat, or question.
Tomašič et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: